The ETV6::ABL1 fusion was recently included in the genetic abnormalities defining the disease category of myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions (MLN-TK) [1, 2]. Here, TKT is linked to Increased total eosinophil count.